JP Stock MarketDetailed Quotes

4577 Daito Pharmaceutical

Watchlist

2242
-46-2.01%

20min DelayMarket Closed Jul 12 15:00 JST

35.20BMarket Cap10.68P/E (Static)

Daito Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)May 31, 2024

(Q4)May 31, 2024

(Q3)Feb 29, 2024

(Q2)Nov 30, 2023

(Q1)Aug 31, 2023

(FY)May 31, 2023

(Q4)May 31, 2023

(Q3)Feb 28, 2023

(Q2)Nov 30, 2022

(Q1)Aug 31, 2022

Total revenue

3.98%46.9B

16.16%12.23B

-5.81%10.55B

5.35%11.93B

1.14%12.18B

3.77%45.1B

6.58%10.53B

0.75%11.2B

5.68%11.33B

2.51%12.04B

Cost of revenue

6.57%37.06B

18.71%9.69B

-2.44%8.45B

6.10%9.22B

4.75%9.7B

8.64%34.77B

8.21%8.16B

7.45%8.66B

9.49%8.69B

9.36%9.26B

Gross profit

-4.76%9.84B

7.39%2.54B

-17.25%2.11B

2.84%2.72B

-10.91%2.47B

-9.84%10.33B

1.33%2.37B

-16.88%2.55B

-5.10%2.64B

-15.23%2.78B

Operating expense

16.05%5.95B

38.52%1.76B

1.90%1.29B

14.60%1.51B

9.25%1.39B

4.44%5.12B

-11.46%1.27B

-2.09%1.27B

3.95%1.32B

39.19%1.28B

Operating profit

-25.23%3.89B

-28.40%789M

-36.20%816M

-8.83%1.21B

-28.03%1.08B

-20.52%5.21B

21.50%1.1B

-27.70%1.28B

-12.66%1.33B

-36.36%1.5B

Net non-operating interest income (expenses)

-241.67%-41M

-375.00%-19M

-333.33%-13M

-200.00%-6M

0.00%-3M

-33.33%-12M

-100.00%-4M

0.00%-3M

0.00%-2M

-50.00%-3M

Non-operating interest income

--0

---3M

--1M

--2M

--0

Non-operating interest expense

241.67%41M

1,800.00%19M

225.00%13M

50.00%6M

0.00%3M

33.33%12M

-50.00%1M

33.33%4M

100.00%4M

50.00%3M

Net investment income

223.53%42M

193.75%15M

-64.15%19M

95.83%-2M

143.48%10M

-144.16%-34M

-366.67%-16M

39.47%53M

-1,700.00%-48M

-176.67%-23M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

474.71%326M

1,058.82%326M

-285.11%-87M

76.09%-22M

-34M

Income from associates and other participating interests

Special income (charges)

-200.00%-3M

-164.29%-9M

-9M

236.36%15M

-106.25%-1M

177.78%14M

-11M

-166.67%-4M

Less:Other special charges

-40.00%3M

190.00%9M

--9M

----

350.00%5M

-131.25%-10M

--0

--11M

166.67%4M

Less:Write off

--0

----

71.43%-4M

----

Other non-operating income (expenses)

-66.67%1M

-60.00%2M

-200.00%-12M

150.00%5M

-91.43%3M

-44.44%5M

78.95%-4M

-33.33%2M

Income before tax

-16.90%4.22B

-27.96%778M

-12.86%1.13B

-0.97%1.22B

-25.71%1.09B

-24.46%5.08B

33.17%1.08B

-28.79%1.29B

-15.06%1.24B

-44.36%1.47B

Income tax

-32.86%1.04B

-175.14%-130M

-11.65%349M

-10.30%392M

-21.14%429M

-25.96%1.55B

31.06%173M

-36.80%395M

-14.48%437M

-33.98%544M

Net income

-9.90%3.18B

0.00%908M

-13.30%776M

4.14%831M

-28.40%663M

-23.77%3.53B

33.73%908M

-24.66%895M

-15.38%798M

-49.04%926M

Net income continuous operations

-9.90%3.18B

0.11%908M

-13.39%776M

4.14%831M

-28.40%663M

-23.79%3.53B

33.58%907M

-24.58%896M

-15.38%798M

-49.06%926M

Noncontrolling interests

-61.11%-116M

-50.00%-48M

-266.67%-11M

-105.56%-37M

-5.26%-20M

-80.00%-72M

-190.91%-32M

76.92%-3M

-100.00%-18M

-171.43%-19M

Net income attributable to the company

-8.47%3.3B

1.70%956M

-12.36%787M

6.50%869M

-27.80%683M

-22.88%3.6B

36.23%940M

-25.23%898M

-14.29%816M

-48.16%946M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-8.47%3.3B

1.70%956M

-12.36%787M

6.50%869M

-27.80%683M

-22.88%3.6B

36.23%940M

-25.23%898M

-14.29%816M

-48.16%946M

Gross dividend payment

Basic earnings per share

-7.74%210

3.67%61.65

-11.79%50.13

6.51%54.95

-27.57%43.27

-25.35%227.6273

37.42%59.4673

-27.11%56.83

-17.71%51.59

-50.62%59.74

Diluted earnings per share

-7.66%210

3.67%61.65

-11.79%50.13

6.50%54.8196

-27.57%43.27

-25.41%227.4273

37.42%59.4673

-26.91%56.83

-17.80%51.4754

-50.62%59.74

Dividend per share

10.00%60

10.00%30

20.00%54.5455

20.00%27.2727

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)May 31, 2024	(Q4)May 31, 2024	(Q3)Feb 29, 2024	(Q2)Nov 30, 2023	(Q1)Aug 31, 2023	(FY)May 31, 2023	(Q4)May 31, 2023	(Q3)Feb 28, 2023	(Q2)Nov 30, 2022	(Q1)Aug 31, 2022
Total revenue	3.98%46.9B	16.16%12.23B	-5.81%10.55B	5.35%11.93B	1.14%12.18B	3.77%45.1B	6.58%10.53B	0.75%11.2B	5.68%11.33B	2.51%12.04B
Cost of revenue	6.57%37.06B	18.71%9.69B	-2.44%8.45B	6.10%9.22B	4.75%9.7B	8.64%34.77B	8.21%8.16B	7.45%8.66B	9.49%8.69B	9.36%9.26B
Gross profit	-4.76%9.84B	7.39%2.54B	-17.25%2.11B	2.84%2.72B	-10.91%2.47B	-9.84%10.33B	1.33%2.37B	-16.88%2.55B	-5.10%2.64B	-15.23%2.78B
Operating expense	16.05%5.95B	38.52%1.76B	1.90%1.29B	14.60%1.51B	9.25%1.39B	4.44%5.12B	-11.46%1.27B	-2.09%1.27B	3.95%1.32B	39.19%1.28B
Operating profit	-25.23%3.89B	-28.40%789M	-36.20%816M	-8.83%1.21B	-28.03%1.08B	-20.52%5.21B	21.50%1.1B	-27.70%1.28B	-12.66%1.33B	-36.36%1.5B
Net non-operating interest income (expenses)	-241.67%-41M	-375.00%-19M	-333.33%-13M	-200.00%-6M	0.00%-3M	-33.33%-12M	-100.00%-4M	0.00%-3M	0.00%-2M	-50.00%-3M
Non-operating interest income	--0	--0	--0	--0	--0	--0	---3M	--1M	--2M	--0
Non-operating interest expense	241.67%41M	1,800.00%19M	225.00%13M	50.00%6M	0.00%3M	33.33%12M	-50.00%1M	33.33%4M	100.00%4M	50.00%3M
Net investment income	223.53%42M	193.75%15M	-64.15%19M	95.83%-2M	143.48%10M	-144.16%-34M	-366.67%-16M	39.47%53M	-1,700.00%-48M	-176.67%-23M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	474.71%326M	0	1,058.82%326M			-285.11%-87M	76.09%-22M	-34M
Income from associates and other participating interests
Special income (charges)	-200.00%-3M	-164.29%-9M	-9M	236.36%15M	0	-106.25%-1M	177.78%14M	0	-11M	-166.67%-4M
Less:Other special charges	-40.00%3M	190.00%9M	--9M	----	----	350.00%5M	-131.25%-10M	--0	--11M	166.67%4M
Less:Write off	--0	----	----	----	----	71.43%-4M	----	----	----	----
Other non-operating income (expenses)	-66.67%1M	-60.00%2M	-200.00%-12M	6M	150.00%5M	-91.43%3M	-44.44%5M	78.95%-4M	0	-33.33%2M
Income before tax	-16.90%4.22B	-27.96%778M	-12.86%1.13B	-0.97%1.22B	-25.71%1.09B	-24.46%5.08B	33.17%1.08B	-28.79%1.29B	-15.06%1.24B	-44.36%1.47B
Income tax	-32.86%1.04B	-175.14%-130M	-11.65%349M	-10.30%392M	-21.14%429M	-25.96%1.55B	31.06%173M	-36.80%395M	-14.48%437M	-33.98%544M
Net income	-9.90%3.18B	0.00%908M	-13.30%776M	4.14%831M	-28.40%663M	-23.77%3.53B	33.73%908M	-24.66%895M	-15.38%798M	-49.04%926M
Net income continuous operations	-9.90%3.18B	0.11%908M	-13.39%776M	4.14%831M	-28.40%663M	-23.79%3.53B	33.58%907M	-24.58%896M	-15.38%798M	-49.06%926M
Noncontrolling interests	-61.11%-116M	-50.00%-48M	-266.67%-11M	-105.56%-37M	-5.26%-20M	-80.00%-72M	-190.91%-32M	76.92%-3M	-100.00%-18M	-171.43%-19M
Net income attributable to the company	-8.47%3.3B	1.70%956M	-12.36%787M	6.50%869M	-27.80%683M	-22.88%3.6B	36.23%940M	-25.23%898M	-14.29%816M	-48.16%946M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-8.47%3.3B	1.70%956M	-12.36%787M	6.50%869M	-27.80%683M	-22.88%3.6B	36.23%940M	-25.23%898M	-14.29%816M	-48.16%946M
Gross dividend payment
Basic earnings per share	-7.74%210	3.67%61.65	-11.79%50.13	6.51%54.95	-27.57%43.27	-25.35%227.6273	37.42%59.4673	-27.11%56.83	-17.71%51.59	-50.62%59.74
Diluted earnings per share	-7.66%210	3.67%61.65	-11.79%50.13	6.50%54.8196	-27.57%43.27	-25.41%227.4273	37.42%59.4673	-26.91%56.83	-17.80%51.4754	-50.62%59.74
Dividend per share	10.00%60	10.00%30	0	10.00%30	0	20.00%54.5455	20.00%27.2727	0	20.00%27.2727	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall